SCHEMBL5645313

SCHEMBL5645313

CC1CCN(C(=O)n2ccnc2)CC1

nearest known ligand 0.49

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
FAAH O00519 4/20 0.49
ALDH1A1 P00352 4/20 0.49
MGLL Q99685 3/20 0.49
LMNA P02545 1/20 0.49
APOBEC3A P31941 1/20 0.43
APOBEC3G Q9HC16 1/20 0.43
SMN1; SMN2 Q16637 2/20 0.43
HPGD P15428 2/20 0.43
RAB9A P51151 2/20 0.43
HTT P42858 1/20 0.43
NPC1 O15118 2/20 0.40
GAA P10253 1/20 0.40
ACHE P22303 1/20 0.39
KMT2A Q03164 2/20 0.39
MEN1 O00255 1/20 0.39
FNTA P49354 2/20 0.38
FNTB P49356 2/20 0.38
GRM5 P41594 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5650379 0.85 FAAH (0.50) FAAHALDH1A1MGLLLMNARAB9A
SCHEMBL13097425 0.83 FAAH (0.47) FAAHALDH1A1MGLLLMNAHPGD
SCHEMBL5646748 0.81 RECQL (0.54) FAAHALDH1A1MGLLLMNASMN1; SMN2
SCHEMBL27885322 0.81 FAAH (0.47) FAAHALDH1A1MGLLLMNAFNTA
SCHEMBL12713291 0.80 FAAH (0.55) FAAHALDH1A1MGLLLMNAFNTA
SCHEMBL30730242 0.80 FAAH (0.55) FAAHALDH1A1MGLLLMNAKMT2A
SCHEMBL13097449 0.80 FAAH (0.46) FAAHALDH1A1MGLLLMNAFNTA
SCHEMBL17275230 0.80 SMN1; SMN2 (0.47) FAAHALDH1A1MGLLLMNASMN1; SMN2
SCHEMBL1911804 0.79 FAAH (0.55) FAAHALDH1A1MGLLLMNAKMT2A
SCHEMBL1687216 0.79 FAAH (0.55) FAAHALDH1A1MGLLLMNAFNTA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7279470-B2 Compounds and uses thereof for decreasing activity of hormone-sensitive lipase NOVO NORDISK A/S (DK) 2007-10-09 US disclosed
US-7067517-B2 Use of compounds for decreasing activity of hormone-sensitive lipase NERO NORDISK A/S (DK) 2006-06-27 US disclosed
EP-1458375-A2 COMPOSITIONS FOR DECREASING ACTIVITY OF HORMONE-SENSITIVE LIPASE NOVO NORDISK A/S (DK) 2004-09-22 EP disclosed
EP-1458374-A2 COMPOUNDS AND USES THEREOF FOR DECREASING ACTIVITY OF HORMONE-SENSITIVE LIPASE NOVO NORDISK A/S (DK) 2004-09-22 EP disclosed
US-20030166644-A1 Compounds and uses thereof for decreasing activity of hormone-sensitive lipase NOVO NORDISK A/S (DK) 2003-09-04 US disclosed
US-20030166690-A1 Use of compounds for decreasing activity of hormone-sensitive NOVO NORDISK A/S (DK) 2003-09-04 US disclosed
WO-2003051842-A2 COMPOSITIONS DECREASING ACTIVITY OF HORMONE-SENSITIVE LIPASE NOVO NORDISK A/S (DK) 2003-06-26 WO disclosed
WO-2003051841-A2 COMPOUNDS AND USES THEREOF FOR DECREASING ACTIVITY OF HORMONE-SENSITIVE LIPASE NOVO NORDISK A/S (DK) 2003-06-26 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030166644-A1 Compounds and uses thereof for decreasing activity of hormone-sensitive lipase LIPE, PNLIP, LPL FAAH 474/4885ALDH1A1 1304/4885MGLL 8/4885
US-20030166690-A1 Use of compounds for decreasing activity of hormone-sensitive LIPE, PNLIP, LPL FAAH 352/4885ALDH1A1 1599/4885MGLL 10/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.